These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8888085

  • 1. The impact of practice guidelines on prescribing patterns of nondepolarizing neuromuscular blocking agents.
    Tschida SJ, Hoey LL, Vance-Bryan K.
    Pharmacotherapy; 1996; 16(5):899-904. PubMed ID: 8888085
    [Abstract] [Full Text] [Related]

  • 2. A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.
    Clarens DM, Kelly KJ, Gilliland SS, Kohls PK, Nahum A, Vance-Bryan K.
    Pharmacotherapy; 1993; 13(6):647-55. PubMed ID: 7905621
    [Abstract] [Full Text] [Related]

  • 3. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH, Murry KR.
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [Abstract] [Full Text] [Related]

  • 4. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA, Weingarten CM, Nagelhout J, Stevenson JG.
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [Abstract] [Full Text] [Related]

  • 5. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR, Rutkowski AF.
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [Abstract] [Full Text] [Related]

  • 6. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ, Rudis MI, Lai K, Petitta A, Lulek M.
    Pharmacotherapy; 1997 Aug; 17(2):327-32. PubMed ID: 9085324
    [Abstract] [Full Text] [Related]

  • 7. Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review.
    Reeves ST, Turcasso NM.
    South Med J; 1997 Aug; 90(8):769-74. PubMed ID: 9258301
    [Abstract] [Full Text] [Related]

  • 8. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN, Singletary TJ.
    Pharmacotherapy; 1997 Aug; 17(6):1322-7. PubMed ID: 9399619
    [Abstract] [Full Text] [Related]

  • 9. Neuromuscular blocking agents in the emergency department.
    Rubin MA, Sadovnikoff N.
    J Emerg Med; 1996 Aug; 14(2):193-9. PubMed ID: 8740751
    [Abstract] [Full Text] [Related]

  • 10. Should ICU patients receive muscle relaxants?
    Coakley J.
    Schweiz Med Wochenschr; 1996 Sep 28; 126(39):1644-8. PubMed ID: 8858758
    [Abstract] [Full Text] [Related]

  • 11. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.
    Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL.
    Muscle Nerve; 1994 Jun 28; 17(6):647-54. PubMed ID: 7910951
    [Abstract] [Full Text] [Related]

  • 12. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    Buck ML, Reed MD.
    Clin Pharm; 1991 Jan 28; 10(1):32-48. PubMed ID: 1825627
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N, Bonada G, Feiss P.
    Acta Anaesthesiol Belg; 1996 Jan 28; 47(4):187-93. PubMed ID: 9093646
    [Abstract] [Full Text] [Related]

  • 14. [Muscle relaxants in the ICU].
    Schneider G.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May 28; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [Abstract] [Full Text] [Related]

  • 15. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR, Kern S, Ficke DJ, Ebert TJ.
    Acta Anaesthesiol Scand; 2005 Mar 28; 49(3):312-5. PubMed ID: 15752394
    [Abstract] [Full Text] [Related]

  • 16. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ, Hoey LL, Vance-Bryan K.
    Pharmacotherapy; 1995 Mar 28; 15(4):540-5. PubMed ID: 7479211
    [Abstract] [Full Text] [Related]

  • 17. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM, Moneret-Vautrin DA, Leynadier F, Laxenaire MC.
    Anesthesiology; 2007 Aug 28; 107(2):245-52. PubMed ID: 17667568
    [Abstract] [Full Text] [Related]

  • 18. Muscle relaxants--pancuronium and vecuronium.
    Ball C, Westhorpe RN.
    Anaesth Intensive Care; 2006 Apr 28; 34(2):137. PubMed ID: 16617633
    [No Abstract] [Full Text] [Related]

  • 19. Consensus guidelines for sustained neuromuscular blockade in critically ill children.
    Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, Hinson G, Mayer A, Morton N, Ralph T, Wolf A, United Kingdom Paediatric Intensive Care Society Sedation, Analgesia and Neuromuscular Blockade Working Group.
    Paediatr Anaesth; 2007 Sep 28; 17(9):881-7. PubMed ID: 17683408
    [Abstract] [Full Text] [Related]

  • 20. Comparisons of the dose-response and recovery time course of vecuronium and atracurium in anesthetized chinese adult patients.
    Xue FS, Li P, Liao X, Li CW, Xu YC, Liu Y, Liu KP, Sun HT.
    Acta Anaesthesiol Taiwan; 2007 Mar 28; 45(1):9-14. PubMed ID: 17424753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.